Skip to main content

Advertisement

Log in

Type 2 diabetes mellitus is associated with impaired cytokine response and adhesion molecule expression in human endotoxemia

  • Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Purpose

Type 2 diabetes is associated with an increased risk of acquiring infectious diseases and developing sepsis. This may partly be due to immune dysfunction. We investigated the in vivo innate immune response of type 2 diabetic persons to an intravenous injection of E. coli lipopolysaccharide (LPS).

Methods

After ethics approval, informed consent and a thorough physical examination, 19 type 2 diabetic patients and 23 healthy controls were included. LPS was given as an intravenous bolus injection of 0.3 ng/kg. Physiological variables, white blood cell count, and plasma concentrations of tumour necrosis factor (TNF), interleukin-6 (IL-6), interleukin-1 receptor antagonist (IL-1ra), and the adhesion molecules E-selectin, vascular adhesion molecule (VCAM)-1, and intracellular adhesion molecule (ICAM)-1 were measured hourly for 8 h.

Results

LPS injection induced a systemic inflammatory response with increases in neutrophils, temperature, heart rate and plasma concentrations of cytokines and adhesion molecules in healthy and type 2 diabetic volunteers. Type 2 diabetes was associated with less pronounced LPS-induced increases in TNF, IL-1ra, VCAM-1 and ICAM-1. There was a trend towards an attenuated upregulation of E-selectin in diabetics, even though the plasma concentration tended to be generally higher compared to healthy controls.

Conclusions

Patients with type 2 diabetes exhibit an attenuated increase in plasma levels of TNF and IL-1ra, as well as an attenuated upregulation of VCAM-1 and ICAM-1 to LPS in vivo. This finding may provide a mechanistic explanation for the adverse outcome seen during infectious diseases in diabetic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1a–f

Similar content being viewed by others

References

  1. Shah BR, Hux JE (2003) Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 26:510–513

    Article  PubMed  Google Scholar 

  2. Geerlings SE, Hoepelman AI (1999) Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 26:259–265

    Article  CAS  PubMed  Google Scholar 

  3. Mooradian AD, Reed RL, Meredith KE, Scuderi P (1991) Serum levels of tumor necrosis factor and IL-1 alpha and IL-1 beta in diabetic patients. Diabetes Care 14:63–65

    Article  CAS  PubMed  Google Scholar 

  4. Hatanaka E, Monteagudo PT, Marrocos MS, Campa A (2006) Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clin Exp Immunol 146:443–447

    Article  CAS  PubMed  Google Scholar 

  5. Chacón MR, Vendrell J, Miranda M, Ceperuelo-Mallafré V, Megía A, Gutiérrrez C, Fernández-Real JM, Richart C, Garcia-España A (2007) Different TNFalpha expression elicited by glucose in monocytes from type 2 diabetes mellitus patients. Atherosclerosis 194:e18–e25

    Article  PubMed  Google Scholar 

  6. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B (1997) Impaired leucocyte functions in diabetic patients. Diabet Med 14:29–34

    Article  CAS  PubMed  Google Scholar 

  7. Marhoffer W, Stein M, Maeser E, Federlin K (1992) Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 15:256–260

    Article  CAS  PubMed  Google Scholar 

  8. Katz S, Klein B, Elian I, Fishman P, Djaldetti M (1983) Phagocytotic activity of monocytes from diabetic patients. Diabetes Care 6:479–482

    Article  CAS  PubMed  Google Scholar 

  9. Notarangelo LD, Badolato R (2009) Leukocyte trafficking in primary immunodeficiencies 1. J Leukoc Biol 85:335–343

    Article  CAS  PubMed  Google Scholar 

  10. Meigs JB, Hu FB, Rifai N, Manson JE (2004) Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 291:1978–1986

    Article  CAS  PubMed  Google Scholar 

  11. Lemaire LC, de Kruif MD, Giebelen IA, van Zoelen MA, van’t Veer C, van der Poll T (2008) Differential dose-dependent effects of prednisolone on shedding of endothelial adhesion molecules during human endotoxemia. Immunol Lett 121:93–96

    Article  CAS  PubMed  Google Scholar 

  12. Astrand PO, Ryhming I (1954) A nomogram for calculation of aerobic capacity (physical fitness) from pulse rate during sub-maximal work. J Appl Physiol 7:218–221

    CAS  PubMed  Google Scholar 

  13. Andreasen AS, Krabbe KS, Krogh-Madsen R, Taudorf S, Pedersen BK, Moller K (2008) Human endotoxemia as a model of systemic inflammation. Curr Med Chem 15:1697–1705

    Article  CAS  PubMed  Google Scholar 

  14. Andreasen AS, Pedersen-Skovsgaard T, Mortensen OH, van HG, Moseley PL, Pedersen BK (2009) The effect of glutamine infusion on the inflammatory response and HSP70 during human experimental endotoxaemia. Crit Care 13:R7

    Article  PubMed  Google Scholar 

  15. Taudorf S, Krabbe KS, Berg RM, Pedersen BK, Moller K (2007) Human models of low-grade inflammation: bolus versus continuous infusion of endotoxin. Clin.Vaccine Immunol 14:250–255

    Article  CAS  PubMed  Google Scholar 

  16. Pickup JC, Mattock MB, Chusney GD, Burt D (1997) NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40:1286–1292

    Article  CAS  PubMed  Google Scholar 

  17. Zozulinska D, Majchrzak A, Sobieska M, Wiktorowicz K, Wierusz-Wysocka B (1999) Serum interleukin-8 level is increased in diabetic patients. Diabetologia 42:117–118

    Article  CAS  PubMed  Google Scholar 

  18. Ohno Y, Aoki N, Nishimura A (1993) In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 77:1072–1077

    Article  CAS  PubMed  Google Scholar 

  19. Geerlings SE, Brouwer EC, Van Kessel KC, Gaastra W, Stolk RP, Hoepelman AI (2000) Cytokine secretion is impaired in women with diabetes mellitus. Eur J Clin Invest 30:995–1001

    Article  CAS  PubMed  Google Scholar 

  20. Foss-Freitas MC, Foss NT, Donadi EA, Foss MC (2006) In vitro TNF-alpha and IL-6 production by adherent peripheral blood mononuclear cells obtained from type 1 and type 2 diabetic patients evaluated according to the metabolic control. Ann NY Acad Sci 1079:177–180

    Article  CAS  PubMed  Google Scholar 

  21. Mastroeni P, Arena A, Costa GB, Liberto MC, Bonina L, Hormaeche CE (1991) Serum TNF alpha in mouse typhoid and enhancement of a Salmonella infection by anti-TNF alpha antibodies. Microb Pathog 11:33–38

    Article  CAS  PubMed  Google Scholar 

  22. Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, Vandenbroucke JP (1997) Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349:170–173

    Article  CAS  PubMed  Google Scholar 

  23. Fujioka N, Mukaida N, Harada A, Akiyama M, Kasahara T, Kuno K, Ooi A, Mai M, Matsushima K (1995) Preparation of specific antibodies against murine IL-1ra and the establishment of IL-1ra as an endogenous regulator of bacteria-induced fulminant hepatitis in mice. J Leukoc Biol 58:90–98

    CAS  PubMed  Google Scholar 

  24. Ruth JH, Bienkowski M, Warmington KS, Lincoln PM, Kunkel SL, Chensue SW (1996) IL-1 receptor antagonist (IL-1ra) expression, function, and cytokine-mediated regulation during mycobacterial and schistosomal antigen-elicited granuloma formation. J Immunol 156:2503–2509

    CAS  PubMed  Google Scholar 

  25. Arnalich F, López-Maderuelo D, Codoceo R, Lopez J, Solis-Garrido LM, Capiscol C, Fernandez-Capitán C, Madero R, Montiel C (2002) Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis. Clin Exp Immunol 127:331–336

    Article  CAS  PubMed  Google Scholar 

  26. van der Poll T, van Deventer SJ, ten Cate H, Levi M, ten Cate JW (1994) Tumor necrosis factor is involved in the appearance of interleukin-1 receptor antagonist in endotoxemia. J Infect Dis 169:665–667

    PubMed  Google Scholar 

  27. Nielson CP, Hindson DA (1989) Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes 38:1031–1035

    Article  CAS  PubMed  Google Scholar 

  28. Krogh-Madsen R, Moller K, Dela F, Kronborg G, Jauffred S, Pedersen BK (2004) Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans. Am J Physiol Endocrinol Metab 286:E766–E772

    Article  CAS  PubMed  Google Scholar 

  29. Mathur N, Pedersen BK (2008) Exercise as a mean to control low-grade systemic inflammation. Mediators Inflamm 2008:109502

    Article  PubMed  Google Scholar 

  30. Sloan RP, Shapiro PA, Demeersman RE, McKinley PS, Tracey KJ, Slavov I, Fang Y, Flood PD (2007) Aerobic exercise attenuates inducible TNF production in humans. J Appl Physiol 103:1007–1011

    Article  PubMed  Google Scholar 

  31. Vinik AI, Erbas T (2001) Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med 68:928–944

    Article  CAS  PubMed  Google Scholar 

  32. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458–462

    Article  CAS  PubMed  Google Scholar 

  33. Shyamsundar M, McKeown ST, O’Kane CM, Craig TR, Brown V, Thickett DR, Matthay MA, Taggart CC, Backman JT, Elborn JS, McAuley DF (2009) Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med 179:1107–1114

    Article  CAS  PubMed  Google Scholar 

  34. Wendel M, Paul R, Heller AR (2007) Lipoproteins in inflammation and sepsis II. Clinical aspects. Intensive Care Med 33:25–35

    Article  CAS  PubMed  Google Scholar 

  35. Thompson PA, Kitchens RL (2006) Native high-density lipoprotein augments monocyte responses to lipopolysaccharide (LPS) by suppressing the inhibitory activity of LPS-binding protein. J Immunol 177:4880–4887

    CAS  PubMed  Google Scholar 

  36. Pickup JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27:813–823

    Article  PubMed  Google Scholar 

  37. van Eijk LT, Dorresteijn MJ, Smits P, van der Hoeven JG, Netea MG, Pickkers P (2007) Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers. Crit Care Med 35:1464–1469

    Article  PubMed  Google Scholar 

  38. Adrie C, Azoulay E, Francais A, Clec’h C, Darques L, Schwebel C, Nakache D, Jamali S, Goldgran-Toledano D, Garrouste-Orgeas M, Timsit JF, OutcomeRea Study Group (2007) Influence of gender on the outcome of severe sepsis: a reappraisal. Chest 132:1786–1793

    Article  PubMed  Google Scholar 

  39. Esper AM, Moss M, Martin GS (2009) The effect of diabetes mellitus on organ dysfunction with sepsis: an epidemiological study. Crit Care 13:R18

    Article  PubMed  Google Scholar 

  40. Puneet P, Moochhala S, Bhatia M (2005) Chemokines in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 288:L3–15

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Ruth Rousing, Hanne Villumsen, Annette Vinding and Andreas Haltorp are acknowledged for their technical assistance. The Centre of Inflammation and Metabolism is supported by a grant from the Danish National Research Foundation (# 02-512-55). This study was further supported by the Beckett Foundation, the Larsen Foundation, the Foundation of Brdr. Hartmann, the Foundation of Direktør Emil Hertz og Hustru Inger Hertz, the A.P. Møller Foundation, the Foundation of the Danish Diabetes Association, the Lærdal Foundation, and the Foundation of Kong Christian den Tiende.

Conflict of interest statement

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anne Sofie Andreasen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andreasen, A.S., Pedersen-Skovsgaard, T., Berg, R.M.G. et al. Type 2 diabetes mellitus is associated with impaired cytokine response and adhesion molecule expression in human endotoxemia. Intensive Care Med 36, 1548–1555 (2010). https://doi.org/10.1007/s00134-010-1845-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-010-1845-1

Keywords

Navigation